Related Experiment Video

Updated: Aug 30, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Description of microangiopathy in children with type 1 diabetes mellitus: a 19-year retrospective study

B Bouhanick1, H Raguin, V Rohmer

  • 1Adult Department of Diabetology, Service de Medecine B, Angers, France. BeBouhanick@chu-angers.fr

Diabetes & Metabolism
|October 4, 2003
PubMed

Insights

This study followed type 1 diabetes patients for over 10 years, finding that good glycemic control is key to preventing complications like retinopathy and nephropathy.

Area of Science:

  • Endocrinology
  • Diabetology
  • Ophthalmology
  • Nephrology

Background:

  • Assesses long-term outcomes for type 1 diabetes patients managed in a university hospital setting.
  • Focuses on patient cohorts transitioning from pediatric to adult care.

Purpose of the Study:

  • To evaluate the progression of retinopathy and nephropathy in type 1 diabetes patients.
  • To identify factors influencing the development and severity of diabetes-related complications.

Main Methods:

  • Retrospective analysis of 50 type 1 diabetes patients with a disease duration of 19 +/- 6 years.
  • Assessment of retinopathy and nephropathy progression, stability, or improvement.
  • Correlation of glycemic control (HbA1c) with complication development.

Main Results:

  • 50% of patients developed retinopathy, with proliferative retinopathy linked to higher HbA1c levels (9.7 +/- 1.6%).
  • 26% of patients had microalbuminuria, also associated with poorer glycemic control (HbA1c 9.3 +/- 2.1%).
  • Glycemic control was similar in patients with non-proliferative retinopathy and those without.

Conclusions:

  • Proliferative retinopathy and nephropathy are significantly related to glycemic control levels.
  • Maintaining optimal glycemic control is crucial for preventing severe diabetes complications.
Abstract

More Related Videos

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans08:21

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...